Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase
- 31 July 1992
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 201 (1) , 208-215
- https://doi.org/10.1016/0014-4827(92)90365-f
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesisCancer and Metastasis Reviews, 1990
- Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.Journal of Clinical Investigation, 1989
- Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin speciesBlood, 1987
- Involvement of both heparanase and plasminogen activator in lymphoma cell‐mediated degradation of heparan sulfate in the subendothelial extracellular matrixJournal of Cellular Physiology, 1986
- Chapter 1: Interferons (IFNs)Published by Elsevier ,1986
- Skeletal muscle metabolism in mice bearing adenocarcinoma III. Activities of alanine and aspartate aminotransferasesExperimental pathology, 1986
- Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidaseNature, 1984
- Heparan Sulfate Degradation: Relation to Tumor Invasive and Metastatic Properties of Mouse B16 Melanoma SublinesScience, 1983
- Extracellular matrix destruction by invasive tumor cellsCancer and Metastasis Reviews, 1982
- Cleavage of laminin by thrombin and plasmin: Alpha thrombin selectively cleaves the beta chain of lamininThrombosis Research, 1981